Sanofi seeks to acquire Solvay’s pharma division
According to reports, Sanofi has approached Solvac, the family-owned holding vehicle that controls 30% of Solvay, and made an offer of E7.2 billion or E85 per share for
XtalPi has entered a strategic partnership valued at more than $400m with an international biopharmaceutical company to develop oral small-molecule therapeutics targeting a G protein-coupled receptor (GPCR).
The pharmaceutical industry has been targeted by the online financial community MeettheBoss. MeettheBoss, originally focused on the financial services sector, has launched a new section dedicated to the
The MRSAid photodisinfection system is designed to reduce Methicillin-resistant Staphylococcus aureus (MRSA) colonization of the anterior nasal passages, the company said. Carolyn Cross, chairman and CEO of Ondine,